开立医疗收盘上涨2.39%，滚动市盈率280.21倍，总市值140.89亿元

Core Insights - The stock price of Kaili Medical closed at 32.56 yuan, up 2.39%, with a rolling PE ratio of 280.21, marking a new low in 38 days, and a total market capitalization of 14.089 billion yuan [1] - The average PE ratio in the medical device industry is 54.32, with a median of 38.11, placing Kaili Medical at the 118th position in the industry ranking [1] - As of the first quarter of 2025, 32 institutions hold shares in Kaili Medical, with a total holding of 24.7034 million shares valued at 734 million yuan [1] Company Overview - Kaili Medical specializes in the independent research, development, production, and sales of medical diagnostic and treatment equipment [1] - The main products include medical ultrasound diagnostic equipment, digestive and respiratory endoscopes, minimally invasive surgical products, and cardiovascular interventional products [1] - The company has over 20 years of experience in the ultrasound industry and is one of the first domestic high-tech enterprises to develop and master core technologies for color ultrasound machines and probes [1] - Kaili Medical ranks second among domestic manufacturers in market share for ultrasound products and tenth globally, indicating strong brand influence and competitiveness [1] Financial Performance - For the first quarter of 2025, Kaili Medical reported revenue of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit of 8.0746 million yuan, down 91.94% year-on-year, with a gross profit margin of 63.19% [1]